Camila A. Picchio

May 25, 2026
From Targets to Real World Impact: A Review of Models of Care for Chronic HBV and HCV in Europe
Hepatitis B virus (HBV) and hepatitis C virus (HCV) remain public health threats in the WHO European region, where an estimated 29 million people live with chronic infection and viral hepatitis-related deaths now surpass those from HIV/AIDS and tuberculosis combined. Although effective prevention tools and antiviral treatments reduce the risk of complications, overall mortality has […]

Read More
September 2, 2025
Estimating the Impact of Displacement from Ukraine on HBV and HCV Prevalence Among Migrants in the European Union, 2024: A Modeling Study
Summary Background In countries with low baseline burdens of hepatitis B and C viruses (HBV, HCV), high levels of migration can impact the burden of viral hepatitis. The screening and treatment of migrants requires different methods and sensitivities than broad-based programs. We aimed to estimate the prevalence of HBV and HCV among migrants in EU-27 […]

Read More

English